210 related articles for article (PubMed ID: 32526899)
1. Design and Development of Novel Urea, Sulfonyltriurea, and Sulfonamide Derivatives as Potential Inhibitors of
Roy S; Mahapatra AD; Mohammad T; Gupta P; Alajmi MF; Hussain A; Rehman MT; Datta B; Hassan MI
Pharmaceuticals (Basel); 2020 Jun; 13(6):. PubMed ID: 32526899
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of novel benzimidazole derivatives as sphingosine kinase 1 inhibitor.
Khairat SHM; Omar MA; Ragab FAF; Roy S; Turab Naqvi AA; Abdelsamie AS; Hirsch AKH; Galal SA; Hassan MI; El Diwani HI
Arch Pharm (Weinheim); 2021 Sep; 354(9):e2100080. PubMed ID: 34128259
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of binding and inhibition mechanism of dietary phytochemicals with sphingosine kinase 1: Towards targeted anticancer therapy.
Gupta P; Mohammad T; Dahiya R; Roy S; Noman OMA; Alajmi MF; Hussain A; Hassan MI
Sci Rep; 2019 Dec; 9(1):18727. PubMed ID: 31822735
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer.
Roy S; Mohammad T; Gupta P; Dahiya R; Parveen S; Luqman S; Hasan GM; Hassan MI
ACS Omega; 2020 Sep; 5(34):21550-21560. PubMed ID: 32905276
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapy.
Gupta P; Mohammad T; Khan P; Alajmi MF; Hussain A; Rehman MT; Hassan MI
Biomed Pharmacother; 2019 Oct; 118():109245. PubMed ID: 31352240
[TBL] [Abstract][Full Text] [Related]
6. Investigation of sphingosine kinase 1 inhibitory potential of cinchonine and colcemid targeting anticancer therapy.
Roy S; Khan S; Jairajpuri DS; Hussain A; Alajmi MF; Islam A; Luqman S; Parvez S; Hassan MI
J Biomol Struct Dyn; 2022 Sep; 40(14):6350-6362. PubMed ID: 33565370
[TBL] [Abstract][Full Text] [Related]
7. Probing the substitution pattern of indole-based scaffold reveals potent and selective sphingosine kinase 2 inhibitors.
Congdon M; Fritzemeier RG; Kharel Y; Brown AM; Serbulea V; Bevan DR; Lynch KR; Santos WL
Eur J Med Chem; 2021 Feb; 212():113121. PubMed ID: 33445156
[TBL] [Abstract][Full Text] [Related]
8. Structural Requirements and Docking Analysis of Amidine-Based Sphingosine Kinase 1 Inhibitors Containing Oxadiazoles.
Houck JD; Dawson TK; Kennedy AJ; Kharel Y; Naimon ND; Field SD; Lynch KR; Macdonald TL
ACS Med Chem Lett; 2016 May; 7(5):487-92. PubMed ID: 27190598
[TBL] [Abstract][Full Text] [Related]
9. Investigating potential of cholic acid, syringic acid, and mangiferin as cancer therapeutics through sphingosine kinase 1 inhibition.
Shakeel I; Khan S; Roy S; Sherwani F; Ahmad SF; Sohal SS; Afzal M; Hassan MI
Int J Biol Macromol; 2023 Dec; 253(Pt 5):127036. PubMed ID: 37788733
[TBL] [Abstract][Full Text] [Related]
10. Lipophilic tail modifications of 2-(hydroxymethyl)pyrrolidine scaffold reveal dual sphingosine kinase 1 and 2 inhibitors.
Li H; Sibley CD; Kharel Y; Huang T; Brown AM; Wonilowicz LG; Bevan DR; Lynch KR; Santos WL
Bioorg Med Chem; 2021 Jan; 30():115941. PubMed ID: 33385956
[TBL] [Abstract][Full Text] [Related]
11. Identification of Sphingosine Kinase-1 Inhibitors from Bioactive Natural Products Targeting Cancer Therapy.
Jairajpuri DS; Mohammad T; Adhikari K; Gupta P; Hasan GM; Alajmi MF; Rehman MT; Hussain A; Hassan MI
ACS Omega; 2020 Jun; 5(24):14720-14729. PubMed ID: 32596609
[TBL] [Abstract][Full Text] [Related]
12. Revealing 2-dimethylhydrazino-2-alkyl alkynyl sphingosine derivatives as sphingosine kinase 2 inhibitors: Some hints on the structural basis for selective inhibition.
Corro-Morón M; Granell A; Ivanova V; Domingo E; Beltrán-Debón R; Barril X; Sanz MJ; Matheu MI; Castillón S; Díaz Y
Bioorg Chem; 2022 Apr; 121():105668. PubMed ID: 35219046
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
Lynch KR; Thorpe SB; Santos WL
Expert Opin Ther Pat; 2016 Dec; 26(12):1409-1416. PubMed ID: 27539678
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate.
Kharel Y; Mathews TP; Gellett AM; Tomsig JL; Kennedy PC; Moyer ML; Macdonald TL; Lynch KR
Biochem J; 2011 Dec; 440(3):345-53. PubMed ID: 21848514
[TBL] [Abstract][Full Text] [Related]
15. A High-Throughput Genetic Complementation Assay in Yeast Cells Identified Selective Inhibitors of Sphingosine Kinase 1 Not Found Using a Cell-Free Enzyme Assay.
Kashem MA; Kennedy CA; Fogarty KE; Dimock JR; Zhang Y; Sanville-Ross ML; Skow DJ; Brunette SR; Swantek JL; Hummel HS; Swindle J; Nelson RM
Assay Drug Dev Technol; 2016; 14(1):39-49. PubMed ID: 26426296
[TBL] [Abstract][Full Text] [Related]
16. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose.
Huang K; Huang J; Chen C; Hao J; Wang S; Huang J; Liu P; Huang H
Cell Signal; 2014 Mar; 26(3):629-38. PubMed ID: 24342046
[TBL] [Abstract][Full Text] [Related]
17. In Silico Identification of Novel Orthosteric Inhibitors of Sphingosine Kinase 1 (SK1).
Bayraktar O; Ozkirimli E; Ulgen KO
Curr Protein Pept Sci; 2018; 19(5):430-444. PubMed ID: 27829348
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases.
Bu Y; Wu H; Deng R; Wang Y
Front Pharmacol; 2021; 12():733387. PubMed ID: 34737701
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship studies of the lipophilic tail region of sphingosine kinase 2 inhibitors.
Congdon MD; Childress ES; Patwardhan NN; Gumkowski J; Morris EA; Kharel Y; Lynch KR; Santos WL
Bioorg Med Chem Lett; 2015 Nov; 25(21):4956-4960. PubMed ID: 25862200
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine Kinase 2 Inhibitors: Rigid Aliphatic Tail Derivatives Deliver Potent and Selective Analogues.
Pashikanti S; Foster DJ; Kharel Y; Brown AM; Bevan DR; Lynch KR; Santos WL
ACS Bio Med Chem Au; 2022 Oct; 2(5):469-489. PubMed ID: 36281302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
